Association Between Serum Lipid Levels and Antiviral Treatment Outcome in Patients with Chronic Hepatitis C
时佳,沈震,苗慧,杨宗国,徐庆年,陆云飞,吕莹,陈晓蓉
DOI: https://doi.org/10.3969/j.issn.1001-5256.2014.06.005
2014-01-01
Abstract:Objective To investigate the association between serum lipid levels and antiviral treatment outcome in chronic hepatitis C (CHC)patients.Methods A total of 171 treatment-naive CHC patients were included in the present retrospective study and received a standard therapy of pegylated interferon (PEG-IFN)plus ribavirin.Serum levels of total cholesterol (TC),triglycerides (TG),low-den-sity lipoprotein cholesterol (LDL -C),high -density lipoprotein cholesterol (HDL -C),apolipoprotein A (apoA),apolipoprotein B (apoB),and other vital indicators in laboratory were determined,and their relationships with treatment responses,hepatitis C virus (HCV) genotypes,and therapy time points (for non-1b type,0,12,and 24 weeks;for 1b type,0,24,and 48 weeks)were analyzed.For nor-mally distributed measurement data,values were expressed as mean ±SD,and statistical analysis was performed by t test and ANOVA;for non-normally distributed data,values were expressed as median and interquartile range,and statistical analysis was performed by rank sum test;for categorical variables,values were expressed as frequency (constituent ratio),and statistical analysis was performed by chi-square test.Univariate and multivariate logistic regression analyses were performed to determine prognostic factors.Results Among the 171 CHC patients receiving PEG-IFN plus ribavirin,81.87%achieved a sustained virological response (SVR),and 18.13%did not;SVR patients showed significantly lower TG and apoB levels than non-SVR patients (P<0.05 ).Compared with patients infected with HCV-1 b and HCV-6a,those with HCV-3 infection had lower serum levels of TC,LDL-C,apoA,and apoB (P<0.05),while the opposite results were observed in terms of the levels of alanine aminotransferase and aspartate aminotransferase (P<0.05).In the SVR group,significant increases in TG and apoB were observed at the end of treatment process ,while a significant decrease in HDL -C was also noted (P <0.05 ).However,no significant changes in serum lipids were observed in non-SVR patients.The univariate logistic regression analysis re-vealed that SVR was closely related to the following factors:age ≤50 years,HCV genotype non -1b,TG ≤3.11 mmol/L,and apoB≤0.63 g/L (P<0.05).The multivariate logistic regression analysis indicated that patients with CHC were more likely to achieve a SVR if they were ≤50 years old with a serum apoB level of≤0.63 g/L.Conclusion Serum lipid levels and age are closely related to the clinical outcome of CHC.Age (≤50 years)and serum apoB level (≤0.63 g/L)are two independent predictors for SVR in CHC patients.